Skip to main content
SpringerLink
Log in

Lifestyle Medicines and the Elderly

  • Current Opinion
  • Published:
Drugs & Aging Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Lifestyle medicines are those used to meet patient aspirations rather than traditionally defined medical need. However, in many cases, the boundary between the two is ill defined and a matter of degree or cultural expectation. Such medicines are not yet widely used by the elderly, but this may change in an increasingly consumerist society. There are ethical, clinical and financial issues to be considered around these drugs, which are not independent.

The ethical issues relate mainly to the rising consumerism in medicine, and whether these and other medicines are consumer goods available almost on demand. The clinical issues concern the balancing of risk and benefit for these medicines, and how we inform patients of these issues. The financial issues are who should pay and whether third party payers can and should ration these medicines and, if so, how. Lifestyle medicines may provoke a debate on the whole issue of rationing.

These issues are not confined to the use of these medicines by the elderly and their resolution will depend on a broader societal debate, in which the elderly need to be active.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Similar content being viewed by others

Explore related subjects

Discover the latest articles, news and stories from top researchers in related subjects.

References

  1. Reissman D. The pros and cons of covering lifestyle drugs. Dis Manage Health Outcomes 1999; 6: 249–51

    Article  Google Scholar 

  2. Labelle R, Stoddart G, Rice T. A re-examination of the meaning and importance of supplier induced demand. J Health Econ 1994; 13: 347–68

    Article  PubMed  CAS  Google Scholar 

  3. Williams SJ, Calnan M. The ‘limits’ of medicalisation?: modern medicine and the lay populace in “late” modernity. Soc Sci Med 1996; 42: 1609–20

    Article  PubMed  CAS  Google Scholar 

  4. Kay-Tee K. Healthy aging. BMJ 1997; 315: 1090–6

    Article  Google Scholar 

  5. Charlton BG. The potential for pharmacological treatment of unpleasant psychological symptoms to increase personal fulfillment in old age. Q J Med 2001; 94: 333–6

    Article  CAS  Google Scholar 

  6. Rivlin M. Protecting elderly people: flaws in ageist arguments. BMJ 1995; 310: 1179–82

    Article  PubMed  CAS  Google Scholar 

  7. Mansfield PR. Report on DTC pharmaceutical promotion for Pharmacy Guild of Australia, 1999 [online]. Available from: http://www.healthyskepticism.org [Accessed 2001 Jul 21]

  8. Thomas HF, Sweetnam PM, Janchawee B, et al. Polypharmacy among older men in South Wales. Eur J Clin Pharmacol 1999; 55: 411–5

    Article  PubMed  CAS  Google Scholar 

  9. Stewart RB, Cooper JW. Polypharmacy in the aged. Drugs Aging 1994; 4: 449–61

    Article  PubMed  CAS  Google Scholar 

  10. Department of Health. National Service Framework for the elderly. London: Department of Health, Jun 2001

    Google Scholar 

  11. Royal College of Physicians of London. Clinical management of overweight and obese patients — with particular reference to the use of drugs. London: Royal College of Physicians of London, London 1999

    Google Scholar 

  12. News in brief. BMJ 2000; 320: 204

  13. Bashford J N, Norwood J, Chapman SR. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database. BMJ 1998; 317: 452–6

    Article  PubMed  CAS  Google Scholar 

  14. Gilbert D, Walley T, New B. Lifestyle medicines. BMJ 2000; 321: 1341–4

    Article  PubMed  CAS  Google Scholar 

  15. Meerding W, Bonneux L, Polder J, et al. Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness study. BMJ 1998; 317: 111–5

    Article  PubMed  CAS  Google Scholar 

  16. Grimley Evans J. The rationing debate. Rationing health care by age: the case against. BMJ 1997; 314: 822

    Article  Google Scholar 

  17. Hall C. Viagra abuse ‘will add £1bn to NHS bill’. Daily Telegraph 1998 Jul 8; 1

    Google Scholar 

  18. Beecham L. UK issues guidance on prescribing Viagra. BMJ 1999; 318: 279

    Article  PubMed  CAS  Google Scholar 

  19. McManus P, Marley J, Birkett DJ, et al. Compliance with restrictions on the subsidized use of proton pump inhibitors in Australia. Br J Clin Pharmacol 1998; 46: 409–11

    Article  PubMed  CAS  Google Scholar 

  20. Leufkens H, Haaijer-Ruskamp F, Bakker A, et al. Scenario analysis of the future of medicines. BMJ 1994; 309: 1137–40

    Article  PubMed  CAS  Google Scholar 

  21. Gilbert D. Lifestyle drugs: who will pay? Scrip Reports. London: PJB Publications, 1999

    Google Scholar 

  22. Bodenheimer T. Affordable prescriptions for the elderly. JAMA 2001; 286(14): 1762–3

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this manuscript. The author has no conflicts of interest that are directly relevant to the content of this manuscript.

Author information

Authors and Affiliations

  1. Department of Pharmacology and Therapeutics, University of Liverpool, The Infirmary, 70 Pembroke Place, Liverpool, L69 3GF, UK

    Tom Walley

Authors
  1. Tom Walley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tom Walley.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walley, T. Lifestyle Medicines and the Elderly. Drugs Aging 19, 163–168 (2002). https://doi.org/10.2165/00002512-200219030-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200219030-00001

Keywords

Search

Navigation